641 related articles for article (PubMed ID: 28629126)
1. Differentiated Thyroid Cancer-Treatment: State of the Art.
Schmidbauer B; Menhart K; Hellwig D; Grosse J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629126
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
Handkiewicz-Junak D; Gawlik T; Rozkosz J; Puch Z; Michalik B; Gubala E; Krajewska J; Kluczewska A; Jarzab B
Eur J Endocrinol; 2015 Dec; 173(6):873-81. PubMed ID: 26423095
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategy for low-risk thyroid cancer in Kanaji Thyroid Hospital.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Yamada T
Endocr J; 2014; 61(1):1-12. PubMed ID: 24067543
[TBL] [Abstract][Full Text] [Related]
6. Postsurgical Management of Differentiated Thyroid Cancer in China.
Wei WJ; Zhang GQ; Luo QY
Trends Endocrinol Metab; 2018 Feb; 29(2):71-73. PubMed ID: 29150318
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory thyroid cancer.
Berdelou A; Lamartina L; Klain M; Leboulleux S; Schlumberger M
Endocr Relat Cancer; 2018 Apr; 25(4):R209-R223. PubMed ID: 29371330
[TBL] [Abstract][Full Text] [Related]
8. Papillary and follicular thyroid carcinoma.
Schlumberger MJ; Torlantano M
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study.
Simon D; Körber C; Krausch M; Segering J; Groth P; Görges R; Grünwald F; Müller-Gärtner HW; Schmutzler C; Köhrle J; Röher HD; Reiners C
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):775-82. PubMed ID: 12029551
[TBL] [Abstract][Full Text] [Related]
11. Recurrent and/or metastatic thyroid cancer: therapeutic options.
Karavitaki N; Vlassopoulou V; Tzanela M; Tzavara I; Thalassinos N
Expert Opin Pharmacother; 2002 Jul; 3(7):939-47. PubMed ID: 12083993
[TBL] [Abstract][Full Text] [Related]
12. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
[TBL] [Abstract][Full Text] [Related]
13. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
15. Approach to and treatment of differentiated thyroid carcinoma.
Pacini F; Castagna MG
Med Clin North Am; 2012 Mar; 96(2):369-83. PubMed ID: 22443981
[TBL] [Abstract][Full Text] [Related]
16. Levothyroxine suppressive therapy in differentiated thyroid cancer treatment.
Drugda J; Čáp J; Kosák M; Gabalec F
Vnitr Lek; 2023; 69(2):128-131. PubMed ID: 37072271
[TBL] [Abstract][Full Text] [Related]
17. [Malignant goiter--thyroid cancer].
Reiners C; Dietlein M; Luster M
Dtsch Med Wochenschr; 2008 Oct; 133(43):2215-28; quiz 2229-30. PubMed ID: 18924056
[No Abstract] [Full Text] [Related]
18. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.
Luster M; Lassmann M; Haenscheid H; Michalowski U; Incerti C; Reiners C
J Clin Endocrinol Metab; 2000 Oct; 85(10):3640-5. PubMed ID: 11061516
[TBL] [Abstract][Full Text] [Related]
20. Treatment of malignant thyroid disease.
Blahd WH
Semin Nucl Med; 1979 Apr; 9(2):95-99. PubMed ID: 482955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
